Close Menu
    What's Hot

    Does the Decline in Life Settlement Provider Numbers Impact Investors?

    13 August 2025

    Member Experience Coming to the Fore in Competitive UK Pension Risk Transfer Market

    13 August 2025

    Is a Geroscience Breakthrough the Black Swan Event for Life Insurers and Pensions?

    13 August 2025
    X (Twitter) LinkedIn
    LinkedIn X (Twitter)
    Life Risk News
    • Home
    • Features

      Does the Decline in Life Settlement Provider Numbers Impact Investors?

      13 August 2025

      Member Experience Coming to the Fore in Competitive UK Pension Risk Transfer Market

      13 August 2025

      Is a Geroscience Breakthrough the Black Swan Event for Life Insurers and Pensions?

      13 August 2025

      Q&A: Carl Groth, Chief Risk Officer, Legal and General Retirement America

      13 August 2025

      Economic Weakness Expected to Accelerate Growth of German Pension Buy-Outs

      13 August 2025
    • Commentary

      Why Is Working-Age Mortality Worsening in the UK?

      13 August 2025

      Navigating Credit Allocations for Buy-In: Why Getting It Right Matters Now

      13 August 2025

      Mental Health Illness and Its Impact on Life Expectancy in the USA

      16 July 2025

      The Dangers of Defaulting to Fast Track

      16 July 2025

      Life Expectancy in Breast Cancer

      12 June 2025
    • Events
    • Magazine
    • News

      Prudential Awarded International Longevity Risk Transfer Mandate by NN Life & Pensions

      11 August 2025

      MMC UK Pension Fund Sedgwick Section Completes Bulk Purchase Annuity Buy-In With Standard Life

      11 August 2025

      National Grid UK Pension Scheme Completes Third Buy-In With Rothesay

      6 August 2025

      Finance of America Announces Repurchase of Blackstone Equity Stake

      6 August 2025

      Kosmos Management Completes Maple Life Financial Acquisition

      5 August 2025
    Subscribe
    Life Risk News
    Home » Q&A: Ryan McTernan, Fifth Season Investments

    Q&A: Ryan McTernan, Fifth Season Investments

    Features 15 January 2025Greg WintertonBy Greg Winterton
    Twitter LinkedIn Email
    Life Risk News Q&A
    Share
    Twitter LinkedIn Email

    The life settlement market, like many other alternative assets, has had to navigate its fair share of challenges in the past few years. Greg Winterton caught up with Ryan McTernan, Senior Managing Director at Fifth Season Investments, to get his take on the state of the space as we begin 2025.

    GW: Ryan, starting with something of a retrospective. What would you say have been the main challenges that the life settlement market generally has had to face in the past couple of years, and how successful has it been in navigating them?

    RM: A couple of challenges come to mind. The first is that we are seeing some investors using life expectancies (LEs) that, in our opinion, are too short, which for us, causes our bids to be less competitive. Unfortunately, I don’t think that there is a quick solution to this, but our opinion is that, over time, these LE companies, and investors relying on them, would be weeded out.

    The second is the PHL Variable Rehabilitation. Thankfully, and by design, we have limited exposure to PHL, however anytime a carrier has issues paying a claim it’s a huge negative for the industry. It raises the question of whether there are other lower grade carriers we should be concerned about.

    GW: A question about interest rates. The last few months has seen the Fed cut rates for the first time since the spring of 2020. What’s your view on the outlook for interest rates this year and how much impact do you think they have on the life settlement market?

    RM: I’d prefer not to comment on the direction of interest rates but I do feel that there is a correlation between the Fed and discount rates we see in the life settlement market. This correlation is not one to one and the life settlement market has a lag, which I would attribute to the time it takes to raise capital and having that capital committed. If the Fed continues to cut, then it’s likely that, in a year from now, firms like ours will be buying at a lower discount rate.

    I’d also add that I wouldn’t list rates as a major challenge. There was a period when our investors were expecting higher returns, and life settlements were lagging other markets, but since that time we’ve been able to deploy capital at higher returns than we were pre increases. The LS market hasn’t increased on par with rates elsewhere, but we have been seeing more attractive opportunities. I understand others may disagree as it’s harder to raise capital, debt costs have increased and it’s possible they had to take write downs on a mark to market basis, but I view it as a net positive.

    GW: Moving onto Fifth Season specifically. The firm, in its current form, is a little over two years old. What have been some of the positives, and what have been some of the challenges for Fifth Season since the acquisition by Owl Rock subsidiaries?

    RM: The biggest positive is their commitment to the asset class, meaning they are willing to commit material dollars and resources to funding us and helping us grow. We’ve had a significant increase in dollars deployed over the past two years, clearly that’s a direct result of our relationship with Owl.

    The biggest challenge, which I would say turned out to be positive, was our growth. We went from a team of less than 10, the majority of which have been together for five or more years, to now 24 employees over two years. The people who have joined have added significant value to our company and investment thesis, but obviously there are growing pains when expanding rapidly.

    GW: A recent report published by ELSA and Conning suggests that diversification and a lack of correlation to liquid assets are the main two reasons for allocating to the space. What’s your view here?

    RM: I agree that most investors are here because of the limited correlation to other assets, but that’s not to say this asset is completely uncorrelated to the broader economy.

    As I mentioned earlier, over the past year or so, we have been able to deploy capital at marginally better returns than we were pre-rate increases. That’s great for us, but that also means the investors selling now are selling for less than they would have several years ago. So, they clearly took an impairment, that was directly related to rate changes.

    GW: Finally, Ryan, looking ahead: What’s your message to investors who are looking at adjusting their portfolios in the next few years now that rates are falling? Why life settlements? 

    RM: We’re always excited to hear about reputable institutional investors interested in the asset class. This is a great asset for investors with long dated investments horizons, but it is not necessarily meant for groups with short term liquidity requirements. One of the countless issues with GWG, for example, was their short-term liquidity needs and another situation like that is the last thing we want for this industry.

    Ryan McTernan is Senior Managing Director at Fifth Season Investments 

    2025 - January Life Settlements Longevity Risk Q&A Secondary Life Markets Volume 4 Issue 1 - January 2025
    Share. Twitter LinkedIn Email

    Related Posts

    Does the Decline in Life Settlement Provider Numbers Impact Investors?

    13 August 2025

    Member Experience Coming to the Fore in Competitive UK Pension Risk Transfer Market

    13 August 2025

    Is a Geroscience Breakthrough the Black Swan Event for Life Insurers and Pensions?

    13 August 2025

    Q&A: Carl Groth, Chief Risk Officer, Legal and General Retirement America

    13 August 2025

    Comments are closed.

    Most Popular

    Does the Decline in Life Settlement Provider Numbers Impact Investors?

    13 August 2025

    Member Experience Coming to the Fore in Competitive UK Pension Risk Transfer Market

    13 August 2025

    Is a Geroscience Breakthrough the Black Swan Event for Life Insurers and Pensions?

    13 August 2025

    Why Is Working-Age Mortality Worsening in the UK?

    13 August 2025
    Ad

    Your trusted source for capital markets participation in Life Risk

    X (Twitter) Instagram LinkedIn
    Life Risk
    • About Life Risk News
    • Get In Touch
    • Our Team
    • Copyright Notice
    • Terms and Conditions
    • Privacy Policy
    • Sitemap
    Coverage
    • Home
    • Features
    • Events
    • Commentary
    Subscribe

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
    Cookie SettingsAccept All
    Manage consent

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
    CookieDurationDescription
    cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
    cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
    cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
    cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
    cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
    viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
    Functional
    Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
    Performance
    Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
    Analytics
    Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
    Advertisement
    Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
    Others
    Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
    SAVE & ACCEPT